# TBE-vaccine to Patients With Rheumatoid Arthritis Who Are Using Immunosuppressive Drugs

> **NCT01131910** · PHASE2 · COMPLETED · sponsor: **Sormland County Council, Sweden** · enrollment: 68 (actual)

## Conditions studied

- Rheumatoid Arthritis
- Exposed to TBE-virus
- Immunosuppression

## Interventions

- **BIOLOGICAL:** TBE-vaccine
- **BIOLOGICAL:** TBE-vaccine
- **BIOLOGICAL:** Vaccination against TBE

## Key facts

- **NCT ID:** NCT01131910
- **Lead sponsor:** Sormland County Council, Sweden
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2011-05-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01131910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01131910, "TBE-vaccine to Patients With Rheumatoid Arthritis Who Are Using Immunosuppressive Drugs". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01131910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*